This brand name is authorized in Germany, Spain, Netherlands
The drug AZARON contains one active pharmaceutical ingredient (API):
|
1
Tripelennamine
UNII FWV8GJ56ZN - TRIPELENNAMINE HYDROCHLORIDE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D04AA04 | Tripelennamine | D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AA Antihistamines for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 03099625 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 58666 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 12104582, 12365076 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 1279, 18198 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
